Dongyan Wang

Dongyan Wang


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024
Verified
Journal Article
Closed access
ZBZhang Boyang
Zhang Boyang
ZYZhou Yang
Zhou Yang
FLFeng Liyuan
Feng Liyuan
SDSui Dan
Sui Dan
HLHe Lei
He Lei
DWDongyan Wang
Dongyan Wang

18 June 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
WLWenQiang Li
WenQiang Li
ELE. Liu
E. Liu
YZYiHao Zhou
YiHao Zhou
ZLZhiChao Liao
ZhiChao Liao
DWDongyan Wang
Dongyan Wang
Ischemic stroke (IS), a leading global cause of mortality and long-term disability, necessitates immediate intervention for eligible patients. Current guidelines mandate intravenous thrombolysis within 4.5 h of symptom onset for individuals without contraindications, achieving vessel recanalization rates up to 85% in treated cohorts. However, therapeutic time windows may extend to 4.5–24 h for select patients when guided by advanced multimodal imaging (CT perfusion or diffusion-weighted MRI) to identify salvageable penumbral tissue. While revascularization remains the cornerstone of acute IS management, emerging evidence underscores angiogenesis as a critical biological process for neurovascular repair and functional recovery during the subacute-to-chronic phases. Natural products (NPs), have demonstrated multiple advantages in the treatment of IS, including multi-target modulation, relatively easy access to raw materials, relatively low price, and the significant advantage of having wide selectivity offer novel opportunities for addressing these limitations. This review systematically analyses 13 major NPs classes including saponins, terpenoids, cycloenol ether terpene glycosides, flavonoids, ketones and macrocycles, phenolic acids, phenylpropanoids, polysaccharides, phenolphthaleins, complexes/extracts, volatile oils, alkaloids, and polymeric materials complexes class of compounds, We elucidate the molecular cascade in which NPs regulate the hypoxia-inducible factor 1α (HIF-1α)/Vascular endothelial growth factor (VEGF), Notch and Wnt/β-catenin signaling pathways to promote vascular regeneration. In particular, our study focuses on the critical role of angiogenesis during the development of IS, highlighting that NPs can enhance neovascularization by alleviating oxidative stress/inflammation, among other pathways. These insights offer translational possibilities for the development of NP-based combination therapies targeting both the acute neuroprotective and chronic recovery phases.

30 January 2025 in Archives of Physical Medicine and Rehabilitation
Verified
Journal Article
Closed access
YZYihao Zhou
Yihao Zhou
SYSiyu Yang
Siyu Yang
DLDongxia Li
Dongxia Li
WLWenqiang Li
Wenqiang Li
CYChen Yang
Chen Yang
DWDongyan Wang
Dongyan Wang

25 September 2024 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
DLDongxia Li
Dongxia Li
DWDongyan Wang
Dongyan Wang
YZYihao Zhou
Yihao Zhou
YZYuan Zhang
Yuan Zhang
SYSiyu Yang
Siyu Yang
RZRuiting Zhang
Ruiting Zhang
Background: Functional magnetic resonance imaging has been used in many studies to explore the neural mechanism of acupuncture in patients with post-stroke motor dysfunction. Inconsistent results have been found in these studies, however. This activation likelihood estimation (ALE) meta-analysis was designed to quantitatively integrate changes in brain activity and the neurological effects of acupuncture on patients with motor dysfunction after stroke.Methods: We searched PubMed, Embase, Web of Science, the Cochrane Library, China Science and Technology Journal Database, the China Biology Medicine, the China National Knowledge Infrastructure, and Wanfang Data Knowledge Service Platform for literature from the establishment of the database until March 21, 2024. Research papers were selected, data extracted, and quality assessment was done independently by two researchers. The GingerALE software was used for meta-analysis, and Jackknife sensitivity analysis was employed to assess result robustness.Results: We ended up analyzing 14 studies that included 235 patients and 100 healthy people. ALE meta-analysis showed that Compared with healthy people, the enhanced brain region in poststroke patients with motor dysfunction was located in the left posterior lobe of the cerebellum, the left inferior frontal gyrus, and the left precuneus (p < 0.001). After acupuncture, the activated regions were mainly located in the left posterior lobe of the cerebellum, the right lentiform nucleus putamen, the right medial frontal gyrus, the right inferior frontal gyrus, the left precuneus, the right middle temporal gyrus, the left claustrum, the left cerebellar tonsil, the right superior marginal gyrus, the inactivated area is located in the right medial frontal gyrus the left precentral gyrus and the right precuneus (p < 0.001).Conclusion: Acupuncture can reestablish motor function by causing extensive changes in the brain function of patients with stroke, which may be the neurological effect of acupuncture therapy on stroke patients.Systematic review registration: https://www.crd.york.ac.uk/prospero/, identifier CRD42024526263.

13 July 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
YZYihao Zhou
Yihao Zhou
XDXu Dong
Xu Dong
YXYating Xing
Yating Xing
RWRuoyu Wang
Ruoyu Wang
SYSiyu Yang
Siyu Yang
DWDongyan Wang
Dongyan Wang
Objective: This systematic review and meta-analysis aimed to assessment effects of electroacupuncture (EA) therapy on intractable facial paralysis.Methods: The articles of EA treatment for intractable facial paralysis were retrieved from seven databases, the publication period was from its inception to November 30, 2022. Primary measure was the total effective rate, and other measures included the cure rate, Portmann scores, House-Brackmann scores, Sunnybrook scores and adverse events. The effect size of meta-analysis was expressed using relative risk (RR) or standardized mean difference (SMD) with 95% confidence interval (CI).Results: A total of 18 studies with 1,119 participants were included, all of them had various aspects of bias risk. Meta-analysis results revealed that EA ways improved total effective rate more effectively compared with non-EA counterparts (RR 1.23, 95% CI 1.17–1.31,I2= 0%, 18 studies, 1119 participants), and improved cure rate more significantly than non-EA groups (RR 2.04, 95% CI 1.70–2.44,I2= 0%, 18 studies, 1119 participants). None of studies reported adverse events.Conclusion: EA therapy is more beneficial for patients with intractable facial paralysis than non-EA, but we lack sufficient evidence to evaluate its safety and follow-up effect. Therefore, more clinical trials with high quality methodologies are needed to further verify long-term effects of EA for IFP and improve the level of evidence.Trial registration: Registration number:CRD42021278541.

4 September 2024 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
RZRuwen Zheng
Ruwen Zheng
XDXu Dong
Xu Dong
TWTianyi Wang
Tianyi Wang
HZHongyan Zhang
Hongyan Zhang
YZYihao Zhou
Yihao Zhou
DWDongyan Wang
Dongyan Wang